19.01.2015 Views

2294 part 1 final report.pdf - Agra CEAS Consulting

2294 part 1 final report.pdf - Agra CEAS Consulting

2294 part 1 final report.pdf - Agra CEAS Consulting

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Prevention and control of animal diseases worldwide<br />

Part I: Economic analysis: prevention versus outbreak costs<br />

5.1.1.2. Key AH problem areas<br />

Argentina was selected as a representative case study in the Americas because of the FMD relevance. Due<br />

to the fact that FMD, <strong>part</strong>icularly in South America, has proven to be a challenge not facing any one<br />

country alone, a regional approach is very important for addressing this animal health problem. Such an<br />

approach is increasingly being taken by the various countries in the region as will be discussed in the<br />

following sections. Therefore, Argentina is being presented here not only on its own merit but also in the<br />

context of its role in the South American region.<br />

FMD is a recurrent disease in South America and appears to be endemic in Bolivia, Ecuador and<br />

Venezuela. The disease occurs sporadically in Argentina, Paraguay, Uruguay, Peru, Colombia and Brazil.<br />

In <strong>part</strong>icular, FMD serotypes O, A, and C are known to occur in the affected regions. The general FMD<br />

situation in South America significantly improved during the 1990s, due both to regional initiatives 95 and<br />

efforts made by individual countries (Figure 12).<br />

Since 2000, however, a number of countries have <strong>report</strong>ed new and significant outbreaks including<br />

Argentina, Brazil, Paraguay and Uruguay. The evolution of FMD outbreaks in Argentina during 1990-<br />

2005 closely mirrors the general trend in South America as depicted in Figure 11. This situation has<br />

resulted in major trading setbacks for the region.<br />

A significant <strong>part</strong> of Central and South America are currently recognised as FMD-free without or with<br />

vaccination, but some of the countries that are not recognised have significant export potential, including<br />

Argentina and Brazil for which only certain zones are recognised FMD-free 96 . The impact of FMD,<br />

<strong>part</strong>icularly in Brazil and Argentina, has global implications since these are major world exporters of<br />

meat. In the case of Argentina, when the first outbreak occurred in 2000, the country had only recently<br />

gained recognition from the OIE as being FMD-free without vaccination 97 .<br />

The OIE currently recognises two exporting zones in Argentina with respect to FMD status. The zone<br />

situated south of the 42° parallel (South Patagonia) is recognised as “FMD-free without vaccination”,<br />

while the zone situated north of the 42° parallel is recognised as “FMD-free with vaccination” 98 . The<br />

95 Since 1987, an Hemispheric Plan for the Eradication of FMD (PHEFA) has been put in place by the countries of<br />

South America. Clinical cases of FMD decreased considerably throughout the continent: during the early 1990s<br />

national laboratories diagnosed an average of 766 cases per year in South America, but by the late 1990s the<br />

continent-wide average had fallen to 130. In 1999, clinical signs of FMD were absent in 60% of all cattle on the<br />

continent (which represented 41% of all South American herds and covered 60% of the continent’s geographical<br />

area) (A160).<br />

96 According to data from PANAFTOSA/PAHO-WHO, OIE FMD zoning in South America covered as at the end of<br />

2005 78% of the total cattle population (which represented 60% of all South American herds and covered 53% of the<br />

continent’s geographical area). [PANAFTOSA: Pan American FMD Centre]<br />

97 In May 1997, Argentina achieved the classification of FMD free with vaccination, in accordance with Chapter<br />

2.1.1 of the OIE Code. In May 2000, the status of FMD free without vaccination was achieved.<br />

98 For the various implications of vaccination see section 4.2.1.4.<br />

Civic <strong>Consulting</strong> • <strong>Agra</strong> <strong>CEAS</strong> <strong>Consulting</strong> 96

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!